-
Applera Corporation - Applied Biosystems Group v. Illumina, Inc. et al DC
- 3:07-cv-02845
- N.D. Cal.
- Judge: William H. Alsup
- Filed: 05/31/2007
- Closed: 02/03/2009
- Latest Docket Entry: 05/25/2016
- PACER
- Docket updated daily
1
Plaintiff
3
Defendants
0
Accused
Products
3
Patents-in-Suit
615
Days in
Litigation
-
Applera Corporation - Applied Biosystems Group v. Illumina, Inc. et al DC
- 3:07-cv-02845
- N.D. Cal.
- Judge: William H. Alsup
- Filed: 05/31/2007
- Closed: 02/03/2009
- Latest Docket Entry: 05/25/2016
- PACER
- Docket updated daily
Causes of Action
Breach of Contract
Other
Unfair Competition
Declaratory Judgment
Patent Invalidity
Patent Non-Infringement
Patent Unenforceability
Patent Non-Infringement
Patent Unenforceability
Market Sector
Medical
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
An oligonucleotide probe of the formula: HO--(3')(B)j(5')--OP(.dbd.O)(O--)NH--(B)k-Bt* wherein: B is a nucleotide or an analog thereof; j is in the range of from 1 to 12; k is in the range of from 1 to 12, such that the sum of j and k is less than
view more
|
Valid (103)
Entry 427 |
-
Infringement
Applera Corporation
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| NA | US 5,750,341 A |
1
|
No infringement
Entry 232
|
| Applied Biosystems/Agencourt probes | US 5,969,119 A |
1
|
No infringement
Entry 427
|
| NA | US 6,306,597 B1 | All Asserted Claims |
No infringement
Entry 232
|
Illumina Incorporated
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| DNA sequencing products | US 5,750,341 A | All Asserted Claims |
Infringement
Entry 432
|
| DNA sequencing products | US 5,969,119 A | All Asserted Claims |
Infringement
Entry 432
|
| DNA sequencing products | US 6,306,597 B1 | All Asserted Claims |
Infringement
Entry 432
|
Solexa Incorporated
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| DNA sequencing products | US 5,750,341 A | All Asserted Claims |
Infringement
Entry 432
|
| DNA sequencing products | US 5,969,119 A | All Asserted Claims |
Infringement
Entry 432
|
| DNA sequencing products | US 6,306,597 B1 | All Asserted Claims |
Infringement
Entry 432
|
